3M Settles PFAS Injury Claims With $7.35B Deal, Takes $5.8B Q4 Charge
MMM sits 29% above its 52-week low of $139.34.
Summary
3M agreed to a broad resolution of PFAS-related personal injury claims in the AFFF multi-district litigation in South Carolina. The deal carries a $7.35 billion nominal commitment paid over nine years, a present value of $5.8 billion, and 3M will book a $5.8 billion pre-tax charge in Q4 2026 as a special item. Management says the charge does not change previously issued 2026 guidance, and the settled claims mostly involve PFAS compounds 3M said in 2000 it would voluntarily phase out. The stock closed at $177.05 before the news, near its 52-week high, so the market had not priced in a settlement of this size. This lands after the October 16 Reuters report that 3M was still fighting Australia's A$2 billion PFAS claim, and it follows the Q3 10-Q that already carried PFAS accruals. The key read: a defined, finite liability replaces open-ended litigation risk, and the special-item treatment keeps adjusted EPS intact.
At the time of this announcement, MMM was trading at $180.00 on NYSE in the Manufacturing sector, with a market capitalization of approximately $91.5B. The 52-week trading range was $139.34 to $184.90. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: dpa-AFX.